Spc Lifesciences Files Draft Red Herring Prospectus For Ipo

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

SPC Lifesciences files draft red herring prospectus for IPO

ri-calendar-2-lineMar 30, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

Pharmaceutical ingredients maker SPC Lifesciences Ltd has filed Draft Red Herring Prospectus (DRHP) papers with the capital market regulator SEBI to raise funds through an initial public offering (IPO).

According to the DRHP papers, the company plans to raise up to Rs 300 crore through fresh issuance of equity shares and an Offer For Sale (OFS) of 89.39 lakh equity shares by its promoter Snehal Rajivbhai Patel. The face value of equity shares is Rs 10 each.

Further, the funds raised from the fresh issue, amounting to Rs 55 crore, will be utilized for the purpose of debt repayment, while Rs 40 crore will be allocated for meeting the company's working capital requirements.

SPC has a USFDA approved facility for 6-Chloro-Hexane-2-One that's used in the manufacture of the cardiovascular drug pentoxifylline.

Vadodara-based pharma company develops pharma intermediates and works with pharmaceutical companies who seek USFDA compliant manufacturing facilities as a part of their supply chain.

Related News

Related Blogs

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Stock chartMutual Fund

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025

0 people read

8 mins read . Aug 18, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions